February 27, 2020
And the band played on. Peloton has come to terms with members of the National Music Publishers’ Association (NMPA), which had brought a lawsuit against the exercise machine maker over alleged copyright infringement. The association said at the time that Peloton had been illegally featuring music from Rihanna, Bruno Mars, Lady Gaga and others.
The parties also said they have now entered a joint...
February 6, 2020
Direct-to-consumer, direct-to-phone. New York City-based home testing startup LetsGetChecked has launched its first mobile app for iOS. Through it, consumers will be able to order more testing kits from the company, integrate with services from wearables partners like Fitbit and Apple, and address the results of their tests one-on-one with a LetsGetChecked professional.
"We want healthcare to be...
December 5, 2019
#Pelotonad. Peloton has found itself in the middle of controversy as a recent television ad released by the company was panned by many as sexist. The roughly 30-second video, in which a husband purchases the connected exercise bike for his wife as a Christmas gift, has generated a backlash consisting of Twitter hashtags, viral parodies and a roughly 10% drop in Peloton’s stock price; however, the...
November 15, 2019
The increased spotlight on Google’s healthcare privacy practices doesn’t seem to be letting up, with the Washington Post publishing a story this morning detailing a botched arrangement between the tech giant and the National Institutes of Health back in 2017.
The two groups had a research arrangement centered on more than 100,000 chest X-ray images provided to Google by the NIH. However,...
September 26, 2019
Connected fitness company Peloton priced its IPO last night, raising $1.16 billion with shares priced at $29 a piece. That price didn't hold for too long, with the company closing its day out at $25.76.
According to Bloomberg, this makes Peloton the third-worst US trading debut in 10 years for companies that have raised at least $1 billion prior to their IPO.
The dip may partly be tied to Peloton...
August 29, 2019
Connected fitness company Peloton released its IPO prospectus Tuesday, revealing grim financials, even by today's startup IPO standards: the company lost nearly $200 million in FY 2019, four times what it lost the previous year. The document also contains plenty of reminders of the company's ongoing legal struggles relating to its music licensing and alleged patent infringement.
Yet, according to...
July 31, 2019
Peloton pulls the plug. Owners of the first generation of Peloton’s exercise bike touchscreens will no longer be receiving new software updates for their device, the company announced in a message on its support page. The touchscreen will still be able to access content, but the company is recommending that these users purchase a hardware upgrade so that they may continue to receive new feature...
June 5, 2019
Peloton, the connected fitness company offering home exercise bikes and treadmills with built-in virtual classes, has announced its intention to IPO by filing a confidential draft statement of its S-1 to the SEC. The company is not disclosing the number of shares they plan to offer or their price range.
For those that count Peloton as a digital health company, it constitutes one of the most...
March 20, 2019
Mail-order menopause treatment. Online men’s and women’s health platform Ro is expanding its services with the launch of a new platform for women experiencing menopause.
Called Rory, the platform treats for hot flashes, vaginal dryness, sleep deprivation and other symptoms of menopause, while also seeking to educate users on their personal health. Much like Ro’s other offerings, the service kicks...
Photo by Carsten Koall/Getty Images
February 26, 2019
FDA draft guidance on BCI devices. The FDA signaled its interest in the development of implanted brain-computer interface (BCI) devices on Friday with the release of a new draft guidance focused on the emerging technology. The new document suggests that non-clinical testing of the devices could precede clinical testing as a means to identify and prevent potential risks prior to use by patients.